Contract facts
NONEINCORPORATION OF NAME CHANGE INTO CONTRACT. PREVIOUS NAME WAS SANOFI PASTEUR INC. NEW NAME IS SANOFI VACCINES US INC. is a federal NONE award for Nac Pharmaceuticals (36E797) held by Sanofi Vaccines Us Inc. Estimated value —. Related solicitation 36E79725R0064.
INCORPORATION OF NAME CHANGE INTO CONTRACT. PREVIOUS NAME WAS SANOFI PASTEUR INC. NEW NAME IS SANOFI VACCINES US INC.
Incumbent footprint
Public recordSanofi Vaccines Us Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36E79726D0009?
36E79726D0009 (Incorporation of NAME CHANGE INTO contract) is a Nac Pharmaceuticals (36E797) award with an estimated value of —, currently held by Sanofi Vaccines Us Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36E797-26-D-0009?
36E797-26-D-0009 is the dashed form of PIID 36E79726D0009 (Incorporation of NAME CHANGE INTO contract), held by Sanofi Vaccines Us Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36E79726D0009?
Nac Pharmaceuticals (36E797) awarded 36E79726D0009 to Sanofi Vaccines Us Inc.
Who is the incumbent on 36E79726D0009?
Sanofi Vaccines Us Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint.
When does Sanofi Vaccines Us Inc’s 36E79726D0009 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.